[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-403463-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-403463-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","hiv-prep-empowering-primary-care-physicians-to-end-the-epidemic","HIV PrEP - Empowering Primary Care Physicians to End the Epidemic","","This presentation, delivered at the 56th Annual Primary Care Review, provides a comprehensive overview of Pre-exposure Prophylaxis (PrEP) for the prevention of HIV. It emphasizes the critical role of primary care physicians in identifying at-risk populations, initiating appropriate pharmacotherapy, and providing longitudinal management. The content details the efficacy of PrEP, analyzes regional HIV epidemic trends, addresses current disparities in utilization, and outlines best practices for patient counseling, follow-up, and adverse effect monitoring to improve HIV prevention outcomes.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/healthcare/","Healthcare",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/hiv-prep-empowering-primary-care-physicians-to-end-the-epidemic/403463/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/hiv-prep-empowering-primary-care-physicians-to-end-the-epidemic/403463.png","ImageObject",300,407,{"name":42,"@type":43},"Jordan Avery","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-27",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What are the primary responsibilities of a primary care physician regarding PrEP?","Question",{"text":63,"@type":64},"Physicians are tasked with identifying patients at risk for HIV, initiating PrEP with the correct dosing strategy, and providing ongoing longitudinal management for those on the medication.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How effective is PrEP in preventing HIV infection?",{"text":68,"@type":64},"Evidence from 20 randomized controlled trials indicates that PrEP significantly decreases the risk of HIV infection, with a relative risk of 0.46. Effectiveness is strongly correlated with adherence, showing even greater efficacy when adherence reaches 70% or higher.",{"name":70,"@type":61,"acceptedAnswer":71},"What challenges currently exist in the effort to end the HIV epidemic via PrEP?",{"text":72,"@type":64},"Key challenges include insufficient PrEP utilization, disparities in HIV diagnoses, and significant missed opportunities for intervention, such as low rates of PrEP uptake among patients diagnosed with STIs in the two years prior to an HIV diagnosis.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},403463,1790694994,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,109,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":107,"slug":108},7,40,"healthcare",{"id":110,"doc_module":4,"doc_module_name":25,"category_name":111,"show_sort_weight":112,"slug":113},8,"Research & Report",30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":106,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":4},1099523882367,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","HIV PrEP: Empowering PCPs to End  \nthe Epidemic  \n56th Annual Primary Care Review February 10, 2024  \nHunter C. Spencer, DO, AAHIVS Assistant Professor of Medicine Div. of General Internal Medicine Oregon Health & Science University  \nLearning Objectives  \n\n| Identify |\n| --- |\n| Identify people at risk for HIV in rural and urban settings |\n\n\n| Initiate |\n| --- |\n| Initiate PrEP with the appropriate dosing strategy |\n\n\n| Provide |\n| --- |\n| Provide longitudinal management for patients on PrEP |\n\nAgenda  \n• Why PrEP  \n• HIV epidemic  \n• PrEP efficacy  \n• What is PrEP?  \n• Pharmacotherapies  \n• Dosing strategies  \n• How to PrEP  \n• Indications  \n• Counseling  \n• Follow up  \n• Adverse Effects  \n• Disparities  \n• Summary  \nOregon’s Persistent Epidemic  \n2022: 242 new cases  \n2013: 233 new cases  \n[https://public.tableau.com/shared/9KNC3FNN9?:display_count=n&:origin=viz_share_link](https://public.tableau.com/shared/9KNC3FNN9?:display_count=n&:origin=viz_share_link)  \nInequity in new HIV Diagnosis  \nInsufficient PrEP Utilization  \nPrEP Prescriptions vs Number Indicated for PrEP, 2022  \nPrEP need is high among PWID  \nSpencer HC, et al. Int J STD AIDS. 2023 doi:10 . 1177/09564624231154302 .  \nMissed Opportunities  \n•Of 243 HIV diagnoses in 2023  \n• 12.3% were ever on PrEP  \n• 13.1% were diagnosed with STI in the two years prior  \nPrEP Works  \n• 20 RCTs (N = 36,57518,837)  \n• Global MSM, HET, PWID  \n• Decreased risk of HIV infection  \n• RR = 0.46 (0.33-0.66)  \n• ARR= −2.0%(95% CI, −2.8% to −1.2%)  \n• NNT=50  \n• Greater adherence was associated with greater efficacy  \n• RR with adherence ≥70% = 0.27 (0.19- 0.39)","cbCaipAsndFZQfL2","https://ap.wps.com/l/cbCaipAsndFZQfL2","pdf",1687112,41,"English","# Learning Objectives\n# Agenda\n# Oregon's Persistent Epidemic\n# Inequity in HIV Diagnosis\n# PrEP Utilization and Need\n# Missed Opportunities\n# PrEP Efficacy and Research","[{\"question\":\"What are the primary responsibilities of a primary care physician regarding PrEP?\",\"answer\":\"Physicians are tasked with identifying patients at risk for HIV, initiating PrEP with the correct dosing strategy, and providing ongoing longitudinal management for those on the medication.\"},{\"question\":\"How effective is PrEP in preventing HIV infection?\",\"answer\":\"Evidence from 20 randomized controlled trials indicates that PrEP significantly decreases the risk of HIV infection, with a relative risk of 0.46. Effectiveness is strongly correlated with adherence, showing even greater efficacy when adherence reaches 70% or higher.\"},{\"question\":\"What challenges currently exist in the effort to end the HIV epidemic via PrEP?\",\"answer\":\"Key challenges include insufficient PrEP utilization, disparities in HIV diagnoses, and significant missed opportunities for intervention, such as low rates of PrEP uptake among patients diagnosed with STIs in the two years prior to an HIV diagnosis.\"}]","HIV PrEP - Empowering Primary Care Physicians to End the Epidemic | PDF",1790540621,103]